Clinical Trial Detail

NCT ID NCT03592576
Title Expanded Access to Navitoclax
Recruitment Available
Gender both
Phase Expanded access
Variant Requirements No
Sponsors AbbVie
Indications

myelofibrosis

lymphoid leukemia

acute lymphoblastic leukemia

Therapies

Navitoclax

Age Groups: adult senior

No variant requirements are available.